GPC BIOTECH AG GPCB (NASDAQ)

$ 1.77
11/18/2008 20:09
Sponsored by
Click here!
Change: unch (unch%)
Volume: 500

Avg. Volume: 19200
P/E Ratio: 0
EPS (Annual): -1.02
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 36,840
Institutional Shareholders: 0.17%
Last: 1.77
Change: unch (unch%)
Prev. Close: 1.77
Open: 1.74
Day's Range: 1.74 - 1.77
52wk Range: 0.66 - 5.67
Market Value: 61,150
Beta: 2.26
12-month EPS Change: 0.00%
Total Return Last 12 Months: -47.27%
Total Return Last 3 Years: -235.32%
Total Return Last 5 Years: -85.05%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on GPCB
Alert me Subscribe

GPC partners pull cancer drug application

(NEW YORK)German biotechnology company GPC Biotech AG said Friday its European partner withdrew an application for the troubled cancer drug candidate satraplatin, a move made by GPC in the U...READ MORE
Jul 25, 2008 6:19PM
Keywords: GPCB, SPPI
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80